LISAvienna: The January edition of or newsletter is available online

Today we not only highlight news item from von Valneva, Hookipa Pharma, ProFem, Aurimod, contextflow, Lithoz, Lexogen, Exscientia, origimm, AFFiRiS and incus, but also feature news on recent funding decisions at aws, the Vienna Business Agency and WWTF.

In addition we update you on the cancellation of joint LISA booths at HIMSS and BIO-Europe Spring, promote events and advanced training opportunities and provide information on funding opportunities and deadlines.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)